Clinical course of severe esophagitis following bevacizumab therapy

Korean J Intern Med. 2022 Jan;37(1):243-244. doi: 10.3904/kjim.2021.143. Epub 2021 Jun 15.
No abstract available

MeSH terms

  • Bevacizumab / adverse effects
  • Esophagitis* / chemically induced
  • Esophagitis* / diagnosis
  • Esophagitis* / drug therapy
  • Esophagitis, Peptic*
  • Humans

Substances

  • Bevacizumab